From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Trials <Trials@USPTO.GOV>
`Wednesday, May 11, 2016 3:06 PM
`Frank Calvosa; Trials
`Nick Cerrito; Eric Stops; Evangeline Shih; Gabriel Brier; Lyndsey Przybylski;
`Joseph.Reisman@knobbe.com; Carol.PitzelCruz@knobbe.com;
`Kerry.Taylor@knobbe.com; BoxRanbaxy332@knobbe.com
`RE: IPR2016-00024 & IPR2016-00738
`
`Counsel,
`
`The parties are authorized to file a joint motion to terminate the proceedings in each case, along with a copy of the
`settlement agreement and a separate request that the settlement agreement be treated as business confidential
`information and be kept separate from the case files under 37 C.F.R. 42.74(c). For guidance on what the joint motion to
`terminate must include, we direct the parties to case IPR2015-00293, Paper 7 (PTAB Jan. 8, 2015).
`
`The papers shall be filed no later than Monday, May 16.
`
`
`
`Thanks,
`Andrew Kellogg,
`Supervisory Paralegal
`Patent Trial and Appeal Board
`USPTO
`andrew.kellogg@uspto.gov
`Direct: 571-272-5366
`
`
`
`From: Frank Calvosa [mailto:FrankCalvosa@quinnemanuel.com]
`Sent: Wednesday, May 11, 2016 2:32 PM
`To: Trials <Trials@USPTO.GOV>
`Cc: Nick Cerrito <NickCerrito@quinnemanuel.com>; Eric Stops <EricStops@quinnemanuel.com>; Evangeline Shih
`<EvangelineShih@quinnemanuel.com>; Gabriel Brier <GabrielBrier@quinnemanuel.com>; Lyndsey Przybylski
`<lyndseyprzybylski@quinnemanuel.com>; Joseph.Reisman@knobbe.com; Carol.PitzelCruz@knobbe.com;
`Kerry.Taylor@knobbe.com; BoxRanbaxy332@knobbe.com
`Subject: IPR2016-00024 & IPR2016-00738
`
`Dear PTAB,
`
`
`We write on behalf of Patent Owner, Jazz Pharmaceuticals, Inc. (“Jazz”), regarding IPR2016-00024 and IPR2016-
`00738. Specifically, we write to respectfully request authorization to file joint motions to terminate these
`proceedings. Jazz and Petitioner Ranbaxy Inc. (“Ranbaxy”) have entered into a confidential settlement agreement,
`which resolves the IPRs and the related district court litigations. Ranbaxy joins in Jazz’s request.
`
`Jazz and Ranbaxy are available to discuss this issue with the Board tomorrow, if necessary. Counsel for Ranbaxy are
`copied on this email.
`
`Best regards,
`
`1
`
`JAZZ EXHIBIT 2001
`Ranbaxy Inc. (Petitioner) v. Jazz Pharms. Ireland Ltd. (Patent Owner)
`Case IPR2016-00738
`
`Page 1 of 2
`
`

`
`
`Frank Calvosa
`
`Associate
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`212-849-7569 Direct
`212-849-7000 Main Office Number
`212-849-7100 FAX
`frankcalvosa@quinnemanuel.com
`www.quinnemanuel.com
`
`NOTICE: The information contained in this e-mail message is intended only for the personal and confidential use of the recipient(s) named above. This message
`may be an attorney-client communication and/or work product and as such is privileged and confidential. If the reader of this message is not the intended
`recipient or agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this document in error and that any
`review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately
`by e-mail, and delete the original message.
`
`2
`
`Page 2 of 2